|
1
|
Di Stefano AL, Enciso-Mora V, Marie Y,
Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A,
Hoang-Xuan K, Delattre JY, et al: Association between glioma
susceptibility loci and tumour pathology defines specific molecular
etiologies. Neuro Oncol. 15:542–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu GY, Shi BZ and Li Y: FoxM1 regulates
Sirt1 expression in glioma cells. Eur Rev Med Pharmacol Sci.
18:205–211. 2014.PubMed/NCBI
|
|
3
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wiedemeyer R, Brennan C, Heffernan TP,
Xiao Y, Mahoney J, Protopopov A, Zheng H, Bignell G, Furnari F,
Cavenee WK, et al: Feedback circuit among INK4 tumor suppressors
constrains human glioblastoma development. Cancer Cell. 13:355–364.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lefranc F, Rynkowski M, DeWitte O and Kiss
R: Present and potential future adjuvant issues in high-grade
astrocytic glioma treatment. Adv Tech Stand Neurosurg. 34:3–35.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang Y, Yin L, Jing H and Zhang H:
MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1
in glioblastoma. Tumour Biol. 36:8943–8951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng YA, Liu TE and Wu Y: microRNA-182
inhibits the proliferation and migration of glioma cells through
the induction of neuritin expression. Oncol Lett. 10:1197–1203.
2015.PubMed/NCBI
|
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Y, Wu D, Tao J, Qu P, Zhou Z and Hou
J: MicroRNA-133 inhibits cell proliferation, migration and invasion
by targeting epidermal growth factor receptor and its downstream
effector proteins in bladder cancer. Scand J Urol. 47:423–432.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang H, Hua D, Zhang J, Lan Q, Huang Q,
Yoon JG, Han X, Li L, Foltz G, Zheng S and Lin B: MicroRNA-127-3p
promotes glioblastoma cell migration and invasion by targeting the
tumor-suppressor gene SEPT7. Oncol Rep. 31:2261–2269.
2014.PubMed/NCBI
|
|
15
|
Lee HK, Bier A, Cazacu S, Finniss S, Xiang
C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Liao H, Deng Z, Yang P, Du N,
Zhanng Y and Ren H: miRNA-205 affects infiltration and metastasis
of breast cancer. Biochem Biophys Res Commun. 441:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Verdoodt B, Neid M, Vogt M, Kuhn V,
Liffers ST, Palisaar RJ, Noldus J, Tannapfel A and
Mirmohammadsadegh A: MicroRNA-205, a novel regulator of the
anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
Int J Oncol. 43:307–314. 2013.PubMed/NCBI
|
|
20
|
Yang G, Zhang P, Lv A, Liu Y and Wang G:
MiR-205 functions as a tumor suppressor via targeting TGF-α in
osteosarcoma. Exp Mol Pathol. 100:160–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lei L, Huang Y and Gong W: miR-205
promotes the growth, metastasis and chemoresistance of NSCLC cells
by targeting PTEN. Oncol Rep. 30:2897–2902. 2013.PubMed/NCBI
|
|
22
|
Mao Y, Wu S, Zhao R and Deng Q: MiR-205
promotes proliferation, migration and invasion of nasopharyngeal
carcinoma cells by activation of AKT signalling. J Int Med Res.
44:231–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong G and Xiong X: miR-205 promotes
proliferation and invasion of laryngeal squamous cell carcinoma by
suppressing CDK2AP1 expression. Biol Res. 48:602015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin C and Liang R: miR-205 promotes
epithelial-mesenchymal transition by targeting AKT signaling in
endometrial cancer cells. J Obstet Gynaecol Res. 41:1653–1660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma Q, Wan G, Wang S, Yang W, Zhang J and
Yao X: Serum microRNA-205 as a novel biomarker for cervical cancer
patients. Cancer Cell Int. 14:812014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du
F, Liu LJ, Liu YH, Liu XD, Jia JF, et al: Identification of
microRNA-205 as a potential prognostic indicator for human glioma.
J Clin Neurosci. 20:933–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu C, Li M, Zhang L, Bi Y, Wang P, Li J
and Jiang X: MicroRNA-205 suppresses the invasion and
epithelial-mesenchymal transition of human gastric cancer cells.
Mol Med Rep. 13:4767–4773. 2016.PubMed/NCBI
|
|
28
|
Yin WZ, Li F, Zhang L, Ren XP, Zhang N and
Wen JF: Down-regulation of microRNA-205 promotes gastric cancer
cell proliferation. Eur Rev Med Pharmacol Sci. 18:1027–1032.
2014.PubMed/NCBI
|
|
29
|
Zhang P, Wang L, Rodriguez-Aguayo C, Yuan
Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, et al: miR-205
acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat
Commun. 5:56712014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H and Fan Q: MicroRNA-205 inhibits
the proliferation and invasion of breast cancer by regulating AMOT
expression. Oncol Rep. 34:2163–2170. 2015.PubMed/NCBI
|
|
31
|
Wang W, Liu J and Wu Q: MiR-205 suppresses
autophagy and enhances radiosensitivity of prostate cancer cells by
targeting TP53INP1. Eur Rev Med Pharmacol Sci. 20:92–100.
2016.PubMed/NCBI
|
|
32
|
Li P, Xue WJ, Feng Y and Mao QS:
MicroRNA-205 functions as a tumor suppressor in colorectal cancer
by targeting cAMP responsive element binding protein 1 (CREB1). Am
J Transl Res. 7:2053–2059. 2015.PubMed/NCBI
|
|
33
|
Kapoor A, Yao W, Ying H, Hua S, Liewen A,
Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, et al: Yap1 activation
enables bypass of oncogenic Kras addiction in pancreatic cancer.
Cell. 158:185–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng J, Lei W, Xiang X, Zhang L, Yu F,
Chen J, Feng M and Xiong J: MicroRNA-506 inhibits gastric cancer
proliferation and invasion by directly targeting Yap1. Tumour Biol.
36:6823–6831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Orr BA, Bai H, Odia Y, Jain D, Anders RA
and Eberhart CG: Yes-associated protein 1 is widely expressed in
human brain tumors and promotes glioblastoma growth. J Neuropathol
Exp Neurol. 70:568–577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng Q and Hong W: The emerging role of
the hippo pathway in cell contact inhibition, organ size control,
and cancer development in mammals. Cancer Cell. 13:188–192. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu YC and Wang YZ: Role of Yes-associated
protein 1 in gliomas: Pathologic and therapeutic aspects. Tumour
Biol. 36:2223–2227. 2015. View Article : Google Scholar : PubMed/NCBI
|
